BCLI$0.85-11.18%
Brainstorm Cell Therapeutics Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: OTC
Mkt Cap:$9.38M
Float & O/S:
Inst Own:
DilutionScan read 33 of BRAINSTORM CELL THERAPEUTICS INC.'s SEC filings and found 11 warrant series, 10 convertibles, 1 ATM program, 4 shelf registrations, 1 S-1 registration and 4 completed offerings on file for BCLI. The latest dilution event on file is a convertible issuance on Jul 6, 2026. Analysis updated Nov 3, 2026.
